NCI and FDA to Expand Proteomics Research into Clinical Studies | GenomeWeb

NEW YORK, July 20 - The National Cancer Institute and the Food and Drug Administration said Friday they are expanding their joint proteomics research program to study the protein profiles of cancer patients in National Institutes of Health clinical studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.